Ajjai Shivaram Alva, MBBS, discusses the shift toward combination therapy versus monotherapy in metastatic renal cell carcinoma.
Ajjai Shivaram Alva, MBBS
Advertisement
Articles by Ajjai Shivaram Alva, MBBS
Advertisement
Latest Updated Articles
Dr. Alva on the Shift Toward Combination Therapy in mRCCPublished: February 15th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA
2
CGTLive®’s Weekly Rewind – December 19, 2025
3
The Implications of the Final Data From Hemgenix’s HOPE-B Trial
4
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
5